Sensus Healthcare to Host Second Quarter 2018 Financial Results and Business Update Conference Call on August 2, 2018

Tuesday, July 24, 2018 General News
Email Print This Page Comment bookmark
Font : A-A+

BOCA RATON, Fla., July 24, 2018 /PRNewswire/ -- Sensus Healthcare, Inc. (NASDAQ: SRTS), a medical device company specializing

in the non-invasive treatment of non-melanoma skin cancers and keloids with superficial radiation therapy (SRT), announces that management will hold a conference call on Thursday, August 2, 2018 at 4:30
p.m. Eastern time
to discuss the financial results for the second quarter ended June 30, 2018. In addition, management will provide a business update and a discussion on recent and upcoming milestones.

To access the conference call, the dial-in numbers are 855-940-9473 (U.S. Toll Free), 412-317-5220 (International) and 855-669-9657 (Canada Toll Free). Please direct the operator to be connected to the Sensus Healthcare call.

Following the conclusion of the conference call, a replay will be available through August 9, 2018 and can be accessed by dialing 877-344-7529 (U.S. Toll Free), 412-317-0088 (International) and 855-669-9658 (Canada Toll Free). All listeners should provide the following replay access code: 10122270. The call will also be archived on the Company's website for a period of time at www.sensushealthcare.com.  

About Sensus Healthcare

Sensus Healthcare, Inc., is a medical device company that is committed to providing non-invasive and cost-effective treatment for non-melanoma skin cancers and keloids. Sensus uses a proprietary low-energy X-ray technology known as superficial radiation therapy (SRT), which is a result of over a decade of dedicated research and development. Sensus has successfully incorporated SRT into its portfolio of treatment devices, the SRT-100™ and SRT-100 Vision™. To date, SRT technology has been used to effectively and safely treat oncological and non-oncological skin conditions in thousands of patients. Sensus recently launched Sensus Laser Systems, three next-generation devices that showcase the latest in technology and function for the aesthetic dermatology market. For more information, visit www.sensushealthcare.com.

Contact: LHA Investor Relations Kim Sutton Golodetz212-838-3777kgolodetz@lhai.com

 

Cision View original content:http://www.prnewswire.com/news-releases/sensus-healthcare-to-host-second-quarter-2018-financial-results-and-business-update-conference-call-on-august-2-2018-300685163.html

SOURCE Sensus Healthcare, Inc.



Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store